Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorderMiryam Yusufov, William F Pirl, Joseph A Greer, Emanuele Mazzola, Kristy L. Dalrymple, James A Tulsky, Ilana M Braun, R. Kathryn McHugh
5 December 2024
Systematic review of prognostic models for predicting recurrence and survival in patients with treated oropharyngeal cancerJanine Dretzke, Ahmad K Abou-Foul, Esther Albon, Bethany Hillier, Katie Scandrett, Malcolm J Price, David J Moore, Hisham Mehanna, Paul Nankivell
5 December 2024
Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trialPeng-Fei Zhang, Wei-Han Zhang, Xi-Jiao Liu, Du He, Kun Yang, Hong-Feng Gou, Jian-Kun Hu
4 December 2024
Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signalsJean-Matthieu L'Orphelin, Angélique Da Silva, Jean Cabon, Joachim Alexandre, Charles Dolladille
3 December 2024
Pembrolizumab (MK-3475) plus platinum and gemcitabine as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (PIPER): a phase 2, multicentre, single-arm protocol study in MalaysiaSok Ching Cheong, Bawani Selvam, Gwo Fuang Ho, Ibtisam Muhamad Nor, Chih Kiang Tan, Yoke Fui Wong, Soo Hwang Teo, Kue Peng Lim, Annie Wai Yeeng Chai, Abqariyah Yahya, Wan Zamaniah Wan Ishak
3 December 2024
Australian Particle Therapy Clinical Quality Registry (ASPIRE) protocol (TROG 21.12): a multicentre prospective study on patients with rare tumours, treated with radiation therapyKelly Skelton, Peter Gorayski, Scott Penfold, Amber Murray, Daniel Hamilton, Adam Yeo, Sophie Jessop, Eunji Hwang, Joshua Dass, Hien Le
27 November 2024
Safety and efficacy of intralesional rituximab injection versus involved site radiation therapy in primary ocular adnexal MALT lymphoma: study protocol for a multicentre randomised controlled trialYaoming Liu, Yang Gao, Ling Jin, Qian Li, Xiaohui Wang, Yujie Wu, Jichao Zhou, Wei Liu, Lili Wang, Yuying Dong, Yajing Zheng, Lu Chen, Jinmiao Li, Shicai Su, Junjie TangSee the full list of authors
27 November 2024
A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UKHilary Glen, Amit Bahl, Louisa Fleure, Noel Clarke, Suneil Jain, Tania Kalsi, Vincent Khoo, Junaid Mobeen
27 November 2024
Real-world patient characteristics and survival outcomes in patients with advanced or recurrent endometrial cancer in England: a retrospective, population-based studySusana Banerjee, Alvaro Ingles Russo Garces, Jamie Garside, Tameera Rahman, Clare Pearson, Kiera Heffernan
24 November 2024
Study protocol of Elective Para-aortic and pelvic versus Pelvic only Irradiation in pelvic node positive Cervical cancer: a multicentric open labelled phase III randomised controlled trial (EPIC Study)Abhishek Shinghal, Satyajit Pradhan, Supriya Chopra, Ankita Rungta Kapoor, Ankita Gupta, Prachi Mittal, Vinay Saini, Jeevanshu Jain, Sanju Sanju, Akhil Kapoor, Prashanth Giridhar, Lincoln Pujari, Zachariah Chowdhury, Sudeep Gupta
24 November 2024
